For his work towards developing a novel cancer immunotherapy that turns tumors into their own vaccines, Fábio Rosa has ...

Tumours have developed many strategies and tricks to gain advantages in the body. Led by cell biology professor Sabine Werner, researchers at ETH Zurich have now discovered another surprising trick ...

A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.

A moving cell looks simple from a distance. One edge pushes forward, the rest follows, and the whole thing creeps along as if ...

Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...

Yerem Yeghiazarians, MD, discusses the importance of understanding why certain cells (like cancer cells) can survive in ...

Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they ...

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they’ve been trying to engineer a cell that’s effective against solid tumors, which ...

A new study sheds light on why promising cancer treatments can produce dramatically different results across patients.

A team led by researchers at Baylor College of Medicine has identified flavonoids, natural compounds found in plants, that are toxic to bladder cancer cells cultured in the lab. The researchers report ...